Prof David MacIntyre, an internationally acclaimed expert in reproductive biomedical research, has been named the new Director of the University of Adelaide's Robinson Research Institute (RRI).
Currently serving as the Professor of Reproductive Systems Medicine and Section Head of Pregnancy, Parturition, and Prematurity at Imperial College London (UK), Prof MacIntyre's groundbreaking research has contributed to enhancing health outcomes for mothers and babies. His work at Imperial College London has led to profound insights into the role of microbial communities in the female reproductive tract, influencing the risk of miscarriage, premature rupture of membranes, and preterm birth.
Prof MacIntyre has pioneered the development of innovative technologies for rapid testing of the vaginal microbiome and treatments aimed at improving maternal and neonatal outcomes.
Expressing enthusiasm about his new role, Prof MacIntyre stated, "I'm excited to bring my experience and passion for improving maternal and neonatal health outcomes to this new role at the RRI, which is home to world-class advances in reproduction, pregnancy, and child health."
The RRI, with a legacy of over 60 years of pioneering research at the University of Adelaide, aims to advance women's and children's health across generations and global communities.
Prof Laura Parry, Acting Deputy Vice-Chancellor (Research) at the University of Adelaide, welcomed Prof MacIntyre’s appointment, saying it will further enrich the existing research at RRI. She anticipates that his appointment will catalyze new approaches in the integration and analysis of genomic, transcriptomic, and microbiomic data.
"I am thrilled to welcome Prof MacIntyre to the University of Adelaide's Robinson Research Institute. With his outstanding research track record and experience, Prof MacIntyre is the latest example of the top talent the university is attracting to help achieve its goal of building a better future for families in Australia and around the world," says Prof Parry.
Prof MacIntyre, who holds a PhD in Reproductive Medicine from the University of Newcastle (Australia), will officially assume the charge at RRI in March.